The MEU is recognised as the premier Phase I unit to undertake clinical trials in respiratory conditions, including Asthma and COPD, performing over 300 studies in this area.
Our database holds over 4,500 asthmatics and nearly 2,000 COPD patients who regularly participate in our trials.
The MEU recruits and delivers in other disease areas including Cystic Fibrosis and Idiopathic Pulmonary Fibrosis and provides a one site solution for umbrella studies in healthy volunteers into patients.
Our bronchoscopy suite enables more invasive pharmacodynamic endpoints to be achieved, as well as studies that require lung penetration models.
